- Home
- Qvt Fund Lp
Insider Trading History of Qvt Fund Lp
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Qvt Fund Lp since 2009.
The trader's CIK number is 1290165.
At the time of the last reporting, Qvt Fund Lp was the 10% Owner of Anadys Pharmaceuticals Inc. (stock ticker symbol ANDS).
Also see all insider trading activities at Anadys Pharmaceuticals Inc.
Note that in the past
QVT Fund LP also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmasset Inc (VRUS) by Qvt Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | VRUS | 0 | $0 | 910,000 | $19,223,100 | 0 | $0 |
Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Qvt Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | ANDS | 351,523 | $509,933 | 6,267,718 | $23,065,202 | 0 | $0 |
2010 | ANDS | 5,409,779 | $8,238,857 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inhibitex Inc (INHX) by Qvt Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | INHX | 0 | $0 | 1,493,091 | $6,324,351 | 0 | $0 |
2009 | INHX | 991,628 | $944,782 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tpc Group Inc. (TPCG) by Qvt Fund Lp
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | TPCG | 0 | $0 | 14,000 | $430,780 | 0 | $0 |
2010 | TPCG | 194,490 | $2,479,747 | 73,600 | $2,268,838 | 0 | $0 |
Insider trading activities at 4 companies by Qvt Fund Lp:
1. Pharmasset Inc (VRUS)
2. Anadys Pharmaceuticals Inc (ANDS)
3. Inhibitex Inc (INHX)
4. Tpc Group Inc. (TPCG)
Table 1. Insider trading of Pharmasset Inc (VRUS) by Qvt Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-09-22 | VRUS | Sale | 100,000 | 22.95 | 2,295,000 |
2009-09-23 | VRUS | Sale | 10,000 | 22.41 | 224,100 |
2009-09-24 | VRUS | Sale | 800,000 | 20.88 | 16,704,000 |
Table 2. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Qvt Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-10-20 | ANDS | Sale | 5,252,700 | 3.68 | 19,329,936 |
2011-10-21 | ANDS | Sale | 364,918 | 3.68 | 1,342,898 |
2011-10-17 | ANDS | Sale | 650,100 | 3.68 | 2,392,368 |
2011-01-03 | ANDS | Buy | 34,209 | 1.41 | 48,234 |
2010-12-29 | ANDS | Buy | 317,014 | 1.46 | 461,255 |
2010-12-30 | ANDS | Buy | 300 | 1.48 | 444 |
2010-12-27 | ANDS | Buy | 1,714,210 | 1.30 | 2,228,473 |
2010-12-28 | ANDS | Buy | 544,690 | 1.39 | 757,119 |
2010-12-23 | ANDS | Buy | 285,790 | 1.21 | 345,805 |
2010-10-20 | ANDS | Buy | 150,000 | 1.65 | 247,500 |
2010-10-15 | ANDS | Buy | 2,301,389 | 1.69 | 3,893,950 |
2010-09-16 | ANDS | Buy | 8,000 | 1.78 | 14,240 |
2010-09-10 | ANDS | Buy | 25,000 | 1.80 | 45,000 |
2010-09-01 | ANDS | Buy | 25,000 | 1.74 | 43,500 |
2010-08-30 | ANDS | Buy | 25,000 | 1.77 | 44,250 |
2010-08-27 | ANDS | Buy | 6,000 | 1.75 | 10,500 |
2010-08-26 | ANDS | Buy | 15,700 | 1.75 | 27,475 |
2010-08-25 | ANDS | Buy | 17,400 | 1.70 | 29,580 |
2010-08-23 | ANDS | Buy | 27,000 | 1.79 | 48,330 |
2010-08-24 | ANDS | Buy | 34,900 | 1.73 | 60,377 |
2010-08-19 | ANDS | Buy | 16,000 | 1.79 | 28,640 |
2010-08-20 | ANDS | Buy | 4,000 | 1.77 | 7,080 |
2010-08-17 | ANDS | Buy | 5,000 | 1.80 | 9,000 |
2010-08-16 | ANDS | Buy | 35,000 | 1.86 | 65,100 |
2010-08-12 | ANDS | Buy | 32,500 | 1.94 | 63,050 |
2010-08-03 | ANDS | Buy | 50,400 | 1.99 | 100,296 |
2010-07-06 | ANDS | Buy | 30,000 | 1.98 | 59,400 |
2010-07-02 | ANDS | Buy | 56,800 | 1.94 | 110,192 |
Table 3. Insider trading of Inhibitex Inc (INHX) by Qvt Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-09-26 | INHX | Sale | 33,900 | 3.03 | 102,615 |
2011-09-27 | INHX | Sale | 200,000 | 3.00 | 600,000 |
2011-05-31 | INHX | Sale | 655,000 | 4.54 | 2,970,425 |
2011-04-07 | INHX | Sale | 129,757 | 4.52 | 586,501 |
2011-04-11 | INHX | Sale | 139,052 | 4.29 | 595,837 |
2011-04-08 | INHX | Sale | 335,382 | 4.38 | 1,468,973 |
2009-12-16 | INHX | Buy | 43,000 | .85 | 36,550 |
2009-12-11 | INHX | Buy | 25,000 | .71 | 17,875 |
2009-12-09 | INHX | Buy | 23,000 | .89 | 20,470 |
2009-12-10 | INHX | Buy | 75,000 | .73 | 54,750 |
2009-12-07 | INHX | Buy | 27,000 | .92 | 24,840 |
2009-12-04 | INHX | Buy | 21,500 | .96 | 20,640 |
2009-12-03 | INHX | Buy | 25,000 | .99 | 24,750 |
2009-12-01 | INHX | Buy | 51,000 | .98 | 49,980 |
2009-12-02 | INHX | Buy | 14,000 | .98 | 13,720 |
2009-11-27 | INHX | Buy | 14,300 | .96 | 13,728 |
2009-11-30 | INHX | Buy | 50,000 | .99 | 49,500 |
2009-11-24 | INHX | Buy | 16,292 | .98 | 15,966 |
2009-11-25 | INHX | Buy | 300 | 1.00 | 300 |
2009-11-23 | INHX | Buy | 13,000 | .99 | 12,870 |
2009-11-20 | INHX | Buy | 11,700 | .99 | 11,583 |
2009-11-19 | INHX | Buy | 11,000 | .98 | 10,780 |
2009-11-17 | INHX | Buy | 9,500 | .98 | 9,310 |
2009-11-18 | INHX | Buy | 85,000 | .99 | 84,150 |
2009-11-11 | INHX | Buy | 100,000 | 1.00 | 100,000 |
2009-11-12 | INHX | Buy | 19,000 | .99 | 18,810 |
2009-11-09 | INHX | Buy | 71,000 | .99 | 70,290 |
2009-11-10 | INHX | Buy | 13,000 | 1.00 | 13,000 |
2009-11-06 | INHX | Buy | 46,000 | .99 | 45,540 |
2009-11-05 | INHX | Buy | 48,000 | .99 | 47,520 |
2009-11-03 | INHX | Buy | 55,000 | .99 | 54,450 |
2009-11-04 | INHX | Buy | 79,000 | 1.00 | 79,000 |
2009-10-30 | INHX | Buy | 27,556 | .99 | 27,280 |
2009-11-02 | INHX | Buy | 17,480 | .98 | 17,130 |
Table 4. Insider trading of Tpc Group Inc. (TPCG) by Qvt Fund Lp
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-12-31 | TPCG | Sale | 14,000 | 30.77 | 430,780 |
2010-12-27 | TPCG | Sale | 49,000 | 30.85 | 1,511,650 |
2010-12-28 | TPCG | Sale | 24,600 | 30.78 | 757,188 |
2010-04-07 | TPCP | Buy | 194,490 | 12.75 | 2,479,747 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Qvt Fund Lp
(10% Owner of Anadys Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.